Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
0.916
-0.044 (-4.54%)
Nov 20, 2024, 4:00 PM EST - Market closed
Cytosorbents Employees
Cytosorbents had 186 employees as of December 31, 2023. The number of employees decreased by 12 or -6.06% compared to the previous year.
Employees
186
Change (1Y)
-12
Growth (1Y)
-6.06%
Revenue / Employee
$202,901
Profits / Employee
-$100,376
Market Cap
50.08M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
111, Inc. | 1,520 |
BGM Group | 298 |
Apyx Medical | 252 |
OptiNose | 132 |
Precision BioSciences | 109 |
Connect Biopharma Holdings | 81 |
Shattuck Labs | 75 |
Kronos Bio | 63 |
CTSO News
- 10 days ago - CytoSorbents And Converge Biotech Announce Strategic Partnership to Expand Sepsis and Critical Care Treatment with CytoSorb in India - GlobeNewsWire
- 11 days ago - Cytosorbents Corporation (CTSO) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - CytoSorbents Submits DrugSorb-ATR Marketing Application to U.S. FDA to Reduce the Severity of Bleeding in Heart Bypass Surgery Patients on the Blood Thinner Ticagrelor and Provides Business Update - GlobeNewsWire
- 3 months ago - CytoSorbents to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment Conference - GlobeNewsWire
- 3 months ago - CytoSorbents Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 months ago - Cytosorbents Corporation (CTSO) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - CytoSorbents Reports Second Quarter 2024 Financial and Operational Results - GlobeNewsWire
- 3 months ago - CytoSorbents Appoints Peter J. Mariani Chief Financial Officer - GlobeNewsWire